| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Inovio Pharmaceuticals, Inc. (INO) has 2 insiders with recent SEC Form 4 filings, including 10 buys and 4 sells. INO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 41.8K | $46.0K | - | |
| Other | 17.9K | $19.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2017 | Kim Jong Joseph | Chief Executive Officer | Sale+OE | 147,180 | $6.54 | $962,483.61 | -3.4% | |
| Mar 27, 2017 | Collins Morton | Director | Buy | 21,300 | $6.25 | $133,188.90 | +74.2% | |
| Aug 29, 2016 | Sardesai Niranjan | Chief Operating Officer | Sale+OE | 21,800 | $9.30 | $202,733.46 | -31.0% | |
| Jun 28, 2016 | Collins Morton | Director | Buy | 10,000 | $9.13 | $91,309.00 | +7.6% | |
| May 18, 2016 | Benito Simon X80 | Director | Sale+OE | 6,250 | $10.37 | $64,818.75 | -26.0% | |
| Apr 15, 2016 | Collins Morton | Director | Buy | 68,400 | $9.52 | $650,924.82 | +66.5% | |
| Sep 30, 2015 | Sardesai Niranjan | Chief Operating Officer | Buy | 4,000 | $5.50 | $22,000.00 | +14.3% | |
| Aug 14, 2015 | Benito Simon X80 | Director | Buy | 6,000 | $7.21 | $43,257.60 | +88.3% | |
| Apr 13, 2015 | Cabrera Angel | Director | Buy | 8,000 | $9.53 | $76,240.00 | +27.8% |